Intraventricular Vancomycin Treatment for Shunt-related Ventriculitis Caused by Methicillin-resistant Staphylococcus Aureus in a Preterm Infant: A Case Report

Pediatr Infect Dis J. 2022 Apr 1;41(4):340-342. doi: 10.1097/INF.0000000000003403.

Abstract

Posthemorragic hydrocephalus is a relatively common condition in prematures, often requiring ventriculoperitoneal shunts. We report a case of methicillin-resistant Staphylococcus aureus infection of a ventriculoperitoneal shunt in a premature neonate which failed conventional intravenous treatment. Despite the absence of published guidelines, we used available data and expert advice to treat the patient with intraventricular vancomycin. The treatment was successful in eradicating the infection without observed toxicity. This case highlights the need for international guidelines on intraventricular treatment for neonates.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cerebral Ventriculitis* / drug therapy
  • Encephalitis* / drug therapy
  • Humans
  • Hydrocephalus* / drug therapy
  • Hydrocephalus* / surgery
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Methicillin-Resistant Staphylococcus aureus*
  • Myelitis*
  • Vancomycin / therapeutic use
  • Ventriculoperitoneal Shunt / adverse effects

Substances

  • Anti-Bacterial Agents
  • Vancomycin